Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Castaman

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2008
Desmopressin for the treatment of haemophiliaG Castaman
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Desmopressin and type II B von Willebrand diseaseG Castaman, F Rodeghiero
Thrombosis and Haemostasis|December 18, 1987
Calibration of lyophilized standards for ristocetin cofactor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curvesF Rodeghiero, G Castaman
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?G Castaman, A Tosetto
Best Practice & Research. Clinical Haematology|November 1, 2001
Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessmentF Rodeghiero, G Castaman
Thrombosis Research|February 15, 1993
Consistency of responses to separate desmopressin infusions in patients with storage pool disease and isolated prolonged bleeding timeG Castaman, F Rodeghiero
Thrombosis Research|February 15, 1995
Platelet ristocetin cofactor (RiCof) in patients with type I "platelet normal" von Willebrand disease correlates with plasma RiCof peak after desmopressin infusionG Castaman, F Rodeghiero
Leukemia|January 1, 1994
The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemiaF Rodeghiero, G Castaman
Thrombosis Research|November 1, 1992
Failure of DDAVP to shorten the prolonged bleeding time of two patients with congenital afibrinogenemiaG Castaman, F Rodeghiero
Haematologica|November 1, 1993
Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemiaG Castaman, F Rodeghiero
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2008
Desmopressin for the treatment of haemophiliaG Castaman
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Desmopressin and type II B von Willebrand diseaseG Castaman, F Rodeghiero
Thrombosis and Haemostasis|December 18, 1987
Calibration of lyophilized standards for ristocetin cofactor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curvesF Rodeghiero, G Castaman
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?G Castaman, A Tosetto
Best Practice & Research. Clinical Haematology|November 1, 2001
Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessmentF Rodeghiero, G Castaman
Thrombosis Research|February 15, 1993
Consistency of responses to separate desmopressin infusions in patients with storage pool disease and isolated prolonged bleeding timeG Castaman, F Rodeghiero
Thrombosis Research|February 15, 1995
Platelet ristocetin cofactor (RiCof) in patients with type I "platelet normal" von Willebrand disease correlates with plasma RiCof peak after desmopressin infusionG Castaman, F Rodeghiero
Leukemia|January 1, 1994
The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemiaF Rodeghiero, G Castaman
Thrombosis Research|November 1, 1992
Failure of DDAVP to shorten the prolonged bleeding time of two patients with congenital afibrinogenemiaG Castaman, F Rodeghiero
Haematologica|November 1, 1993
Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemiaG Castaman, F Rodeghiero
Pageof 20